Experts are divided over the delay in the second doses of Covid-19 vaccine. Here’s why

“My view is that the weight of the evidence suggests that we would probably save more lives by delaying second doses than by insisting on the schedule tested in the trials,” he said.

However, not all experts agree that changing dosing schedules is a good idea.

“Secondly, we really do not know if you will delay the second dose for long,” he said. In other words, there is not much research since Covid-19 vaccines have only recently been developed.

While debates over the postponement of the second doses continue in the United States, a slow rollout of vaccines, more deaths with Covid-19 and the spread of newly identified coronavirus variants that appear more transmissible.

Getting second doses is a priority, but ‘there is some room for maneuver’

It is still recommended that people get their second dose of Covid-19 vaccine on time, said Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, said Monday during a virtual information session in the White House.

“Until we have further data,” Walensky said, “people should continue to follow the data of trials by continuing the schedule of two doses 21 days apart for the Pfizer / BioNTech vaccine and 28 days apart for the Modern. vaccine. These are the two vaccines currently allowed for emergency use in the United States.

“The policy is that we definitely want everyone who gets a first dose to get their second dose,” said Dr. Anthony Fauci, chief medical adviser to President Biden and director of the National Institute of Allergy and Infectious Diseases, said during Monday’s briefing.

But also on Monday, during a meeting of the International AIDS Society, Fauci said that if there are only a few weeks too late, there is no cause for concern. “There’s some wrapping room,” he said. “It’s not the end of the world if you delay it a little bit. If you want to delay it by six months, it’s different.”

Changes to the coronavirus vaccination scheme would not start with the FDA, the agency says

If the second doses are delayed, it is in violation of the vaccination schedules approved under the U.S. Food and Drug Administration.

In January, the FDA made it clear that it did not intend to change coronavirus vaccine vaccination schedules – and to make such adjustments, the vaccine manufacturer would have to specifically ask the agency to adjust the authorization.

CNN confirmed with the FDA in January that if a manufacturer requests a change in its emergency use authorization, the manufacturer must submit data to the FDA that supports the requested change.

Some experts argue that there is evidence to support a possible change.

‘We need to have a thorough overview and discussion of this’

Lipsitch of Harvard University is in favor of distributing the vaccine dose in a larger population, rather than doubling the dose for half the population. “If you can get at least half the benefit, it’s better to spread it out,” he said.

Here's how some of the leading coronavirus vaccines work

For the Pfizer / BioNTech vaccine, called BNT162b2, the data indicate that the vaccine has 52% efficacy after only one dose and then provides 95% protection against Covid-19 after two doses.

In a Phase 3 trial conducted at 99 sites in the United States, the data suggest that Moderna’s vaccine shows mRNA-1273 efficacy after the first dose.

But trials have not been conducted to test single doses of mRNA vaccines.

Some emerging evidence in a pre-printed article, posted on the online server medrxiv.org on Monday, found that people previously infected with the virus tended to have antibody levels at or higher than those of people who received both doses. , but has never been infected before. The study does not specify which participants received the vaccine.
What we know about Moderna's coronavirus vaccine and how it differs from Pfizer
For many other vaccines – such as chickenpox, HPV and measles, mumps and rubella vaccines, their second dose of booster shots are given several months later, said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University. of Minnesota, told CNN Monday.

“At this point, everything we know about vaccines suggests that protection can actually be improved by giving a booster a few months after the first dose,” said Osterholm, a coronavirus consultant for the Biden Transition Team.

Osterholm pointed to a letter-to-the-editor that was published last week in the journal Clinical Infectious Diseases, in which dr. Stanley Plotkin of the University of Pennsylvania and dr. Neal Halsey of Johns Hopkins University calculated how many people could be protected. against Covid-19 when given as single doses.

The researchers assumed: “Assume that 1 million people need to be vaccinated, but that there are only 1 million doses available. If two doses are given to each vaccine and its effectiveness is 95%, 475,000 people will be protected. If single doses are given and the efficiency is 80%, 800 000 people will be protected. ‘

Osterholm said that continuing to be vaccinated – even with just one dose – is urgent as more coronavirus variants spread, including the B.1.1.7 variant first identified in the UK, B.1.351 first identified in South Africa, the P .1 variant first identified in Brazil and the L452R first seen in California.
Studies suggest that vaccinated people are protected against new Covid-19 variants

“We need to have a thorough review and discussion of this as soon as possible, because you know that this new variant B.1.1.7 could cause an increase in our cases within a few weeks,” Osterholm said. He described the rise of these variants as similar to a hurricane approaching the horizon.

“I feel like I’m sitting here on a beautiful beach – the light breeze, perfect blue sky and all – and I tell them to start evacuating. People say, ‘Are you crazy?’ “But I see that there is a category five hurricane 450 kilometers south,” Osterholm said. “That is the challenge. How do you get people into action? ”

However, other experts argue that the risk that you may be fed longer between diagnoses is more sensitive to the new coronavirus and its variants.

Overall, Fauci said Monday that getting vaccinated against Covid-19 could prevent more coronavirus variants from popping up in the future.

“You need to be vaccinated when it is available as quickly and as quickly as possible,” Fauci said during the White House letter Monday, adding that viruses cannot mutate if they do not recur.

White House is concerned about providing doses

The Biden administration on Monday expressed concern that healthcare providers could essentially store Covid-19 vaccine doses for second shots that could be administered for initial shots.

White House warns suppliers against vaccination doses
“We believe that some healthcare providers regularly withhold doses intended as first doses and instead keep them in the reserve for second doses for patients,” Andy Slavitt, senior adviser to White House Covid-19, said at the virtual information session of Said Monday. “We want to be clear that we understand why healthcare providers did this, but that it does not have to happen, nor should it happen.”
As of Monday, nearly 50 million doses of coronavirus vaccine have been distributed across the United States and about 32 million doses have been administered so far, according to the CDC.

CDC data show that about 26 million people have received at least one dose so far – but almost 6 million have received their two doses.

“On January 20, states administered 46% of their inventory. That is 62% today. We are focused on it every hour every day,” Slavitt said Monday.

Slavitt suggested that patients’ appointments for a first dose be canceled in some cases, and insisted that it was urgently necessary to take out first doses as soon as possible. He said the government wanted to take a look at the planning of vaccines for three weeks last week, to allay concerns that the second doses could be withheld.

CNN’s Jen Christensen, Amanda Sealy, Michael Nedelman and Betsy Klein contributed to this report.

.Source